Cite
Secreted amyloid precursor protein alpha as a therapeutic for insulin signaling dysfunction in the nervous system
MLA
Albensi, Benedict (Pharmacology and Therapeutics) Hatch, Grant (Pharmacology and Therapeutics) Czubryt, Michael (Physiology and Pathophysiology) Prado, Marco (Western University), et al. Secreted Amyloid Precursor Protein Alpha as a Therapeutic for Insulin Signaling Dysfunction in the Nervous System. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1198413040&authtype=sso&custid=ns315887.
APA
Albensi, B. (Pharmacology and T. H. G. (Pharmacology and T. C. M. (Physiology and P. P. M. (Western U., Glazner, G. (Pharmacology and T., & Aulston, B. (2018). Secreted amyloid precursor protein alpha as a therapeutic for insulin signaling dysfunction in the nervous system.
Chicago
Albensi, Benedict (Pharmacology and Therapeutics) Hatch, Grant (Pharmacology and Therapeutics) Czubryt, Michael (Physiology and Pathophysiology) Prado, Marco (Western University), Gordon (Pharmacology and Therapeutics) Glazner, and Brent Aulston. 2018. “Secreted Amyloid Precursor Protein Alpha as a Therapeutic for Insulin Signaling Dysfunction in the Nervous System.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1198413040&authtype=sso&custid=ns315887.